|
|
Article: New Data Show Fewer ER Visits and Hospitalizations Among Asthma Patients Treated With Advair Diskus(R).
- Article from:
- PR Newswire
- Article date:
- November 11, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Data Presented at the American College of Allergy, Asthma and Immunology Annual Meeting
PHILADELPHIA, Nov. 11 /PRNewswire/ -- An observational study of more than 64,000 asthma patients demonstrated that patients receiving treatment with Advair Diskus (fluticasone propionate and salmeterol inhalation powder) had a significant risk reduction in emergency department visits due to asthma versus patients treated with fluticasone propionate (FP) alone. A second analysis of clinical trials of patients treated with salmeterol plus FP (the components found in Advair) reported fewer asthma exacerbations when compared to patients treated with FP alone. These findings ...